Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Wall Street Loses Faith in PayPal’s Near-Term Prospects

Robert Sasse by Robert Sasse
January 6, 2026
in Analysis, E-Commerce, Market Commentary, Nasdaq, Tech & Software
0
PayPal Stock
0
SHARES
24
VIEWS
Share on FacebookShare on Twitter

PayPal Holdings, Inc. is entering the new year facing a notable retreat in support from major financial institutions. A cluster of prominent investment banks have downgraded their outlooks for the digital payments company in a short span, citing concerns over weakening U.S. consumer spending and its direct impact on transaction volumes.

A Wave of Downgrades Hits the Stock

This pessimistic shift culminated on January 5, when Monness Crespi Hardt lowered its rating from “Buy” to “Neutral.” This move followed a series of similar actions by other heavyweight analysts in recent weeks:

  • JPMorgan issued a “Sell” recommendation on December 4, setting a price target of $70.
  • Bank of America downgraded the stock to “Neutral” on December 11, with a $68 target.
  • Morgan Stanley cut its rating to “Underweight” on December 18, projecting a share price of $51.

Citi analyst Bryan Keane maintained a “Hold” stance on January 5, but his price target of $60 offers minimal upside from the current trading level near $59.40, underscoring the widespread caution.

Institutional and Insider Selling Adds Pressure

The bearish sentiment extends beyond analyst notes. D.A. Davidson & Co. significantly reduced its stake, selling 66,407 shares in the third quarter—a cut of nearly 25%. This institutional selling was mirrored by activity within the company; corporate insiders disposed of more than 36,000 shares over the last three months.

Should investors sell immediately? Or is it worth buying PayPal?

Historically Cheap Valuation Fails to Attract Buyers

Despite the sell-off, PayPal’s fundamental metrics appear inexpensive. The stock trades at a price-to-earnings (P/E) ratio of just under 12, a level substantially below its historical average and far removed from the multiples above 20 common among other technology stocks. The business remains profitable, generating revenue of $32.91 billion and a net income of $4.92 per share.

However, the market is interpreting this low valuation as a warning sign rather than an opportunity. Shares are hovering close to their 52-week low of $55.85 and have declined approximately 30% year-over-year. Investors seemingly lack confidence in PayPal’s ability to sustain growth within the intensely competitive digital payments landscape.

All Eyes on the February Earnings Report

The company’s upcoming quarterly report, scheduled for February 3, 2026, is viewed as a critical test. It will reveal whether the current pessimistic analyst forecasts for 2026 are justified. Unless PayPal’s results and forward guidance deliver a positive surprise, the $60 price level is expected to act as a firm resistance point. The technical picture reinforces this downtrend, with the stock trading below both its 50-day moving average ($62.70) and its 200-day moving average ($67.81).

Ad

PayPal Stock: Buy or Sell?! New PayPal Analysis from February 7 delivers the answer:

The latest PayPal figures speak for themselves: Urgent action needed for PayPal investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

PayPal: Buy or sell? Read more here...

Tags: PayPal
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Potbelly Stock
Analysis

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

February 7, 2026
Next Post
Intel Stock

Intel Stock Gains Momentum on Key Product Launch and Analyst Upgrade

FS KKR Capital Stock

FS KKR Capital Shares Face Persistent Selling Pressure

ASML Stock

ASML Shares Surge to Record High Amid Semiconductor Boom

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com